Implementation of guidelines for the prevention of diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Diabetes Care

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.27.3.803PMID 14988308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Smoking and diabetes.

  2003cited by this paper
• Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden

  2003cited by this paper
• Trends in hypertension management in Type I diabetes across Europe, 1989/1990 – 1997/1999

  2003cited by this paper
• The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients.

  2003cited by this paper
• Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

  2003cited by this paper
• Polymorphisms in the nephrin gene and diabetic nephropathy in type 1 diabetic patients.

  2003cited by this paper
• The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.

  2003cited by this paper
• Trends in hypertension management in Type I diabetes across Europe, 1989/1990 – 1997/1999

  2002cited by this paper
• Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

  2002cited by this paper
• Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study

  2001cited by this paper
• Smoking and diabetes: readiness for change and provider advice.

  1999cited by this paper
• Smoking and diabetes.

  1999cited by this paper
• Prevention of diabetic renal disease with special reference to microalbuminuria.

  1995cited by this paper
• Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study

  1994cited by this paper
• Declining incidence of nephropathy in insulin-dependent diabetes mellitus.

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

  1988cited by this paper
• Assessing hypertension control in the community: the need for follow-up measurements to ensure clinical relevance.

  1987cited by this paper
• Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy

  1982cited by this paper

• Disease management, outcomes, and healthcare resource utilization in real-life clinical practice of diabetes and diabetic kidney disease in Finland.

  2025cites this paper
• THE STUDY OF AUTONOMIC FUNCTIONS IN YOUNG NONDIABETIC OFFSPRINGS OF TYPE 2 DIABETES MELLITUS PARENTS BY FREQUENCY DOMAIN ANALYSIS OF HEART RATE VARIABILITY

  2022cites this paper
• Evaluation of coronary function in female rats with severe type 1 diabetes: Effects of combined treatment with insulin and pyridoxamine.

  2022cites this paper
• The Study of Autonomic Functions in Young Nondiabetic Offsprings of Type 2 Diabetes Mellitus Parents by Time Domain Analysis of Heart Rate Variability

  2017cites this paper
• Bacterial endotoxins in type 1 diabetes

  2016cites this paper
• Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients

  2015cites this paper
• Lipid profile and micro- and macrovascular complications in type 1 diabetes

  2015cites this paper
• Higher risk of microvascular complications in smokers with type 1 diabetes despite intensive insulin therapy.

  2014cites this paper
• Early autonomic dysfunction in type 1 diabetes : Insights into its significance and mechanisms

  2014cites this paper
• Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study

  2013cites this paper
• TYPE 1 DIABETES

  2013cites this paper
• HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes

  2013cites this paper
• Risk factors for retinopathy in type 1 diabetes

  2013cites this paper
• Longitudinal trends in use and costs of prescription medication in patients with type 1 diabetes: The impact of renal disease

  2013cites this paper
• Higher age at onset of type 1 diabetes increases risk of macular oedema

  2013cites this paper
• ZNACZENIE POŚREDNICH WYKŁADNIKÓW INSULINOOPORNOŚCI W ROZWOJU PRZEWLEKŁYCH POWIKŁAŃ CUKRZYCY TYPU 1

  2012cites this paper
• The risk of proliferative retinopathy in siblings with Type 1 diabetes

  2012cites this paper
• Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy?

  2012cites this paper
• Manidipine treatment in patients with albuminuria not sufficiently reduced with renin–angiotensin system blockers

  2010cites this paper
• Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes

  2010cites this paper
• Renal protection in diabetes: lessons from ONTARGET®

  2010cites this paper
• The impact of the metabolic syndrome and parental risk factors in patients with type 1 diabetes

  2009cites this paper
• Genetic and Environmental Pathways in Type 1 Diabetes Complications

  2008cites this paper
• Heritability of Proliferative Diabetic Retinopathy

  2008cites this paper
• Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation

  2008cites this paper
• Glycosylation inhibitors, PKC inhibitors and related interventions against complications

  2007cites this paper
• Navigating pathways affecting type 1 diabetic kidney disease

  2007cites this paper
• Diabetic patients treated with dialysis: complications and quality of life

  2007cites this paper
• Lowering of Blood Pressure—The Lower, the Better? Patients with

  2006cites this paper
• Novel therapeutics for diabetic micro- and macrovascular complications.

  2006cites this paper
• Factors influencing the risk of diabetic nephropathy : analyses of genes, smoking and diet

  2006cites this paper
• [Compliance with the 2002 consensus document of the Spanish Society of Nephrology for the control of diabetic nephropathy in Catalonia (ECCODIAB)].

  2006cites this paper
• Lowering of Blood Pressure—The Lower, the Better? Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Ann Intern Med 144: 884–893, 2006

  2006cites this paper
• Nephrology beyond JASN

  2006cites this paper
• Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark.

  2006cites this paper
• Cyclic Relationships Between Diabetic Nephropathy and Cardiovascular Risk Factors

  2005cites this paper
• [Effect of glycemic control on microalbuminuria and arterial blood pressure in patients with type 1 diabetes].

  2005cites this paper
• Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate‐to‐severe reductions in renal function

  2005cites this paper
• Current literature in diabetes.

  2005cites this paper
• Genetics and molecular biology.

  2005cites this paper